K253911 is an FDA 510(k) clearance for the Derma-2. Classified as System, Telethermographic (adjunctive Use) (product code LHQ), Class I - General Controls.
Submitted by Neko Health AB (Danderyd, SE). The FDA issued a Cleared decision on May 20, 2026 after a review of 163 days - an extended review cycle.
This device falls under the Radiology FDA review panel, regulated under 21 CFR 884.2980 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.
View all Neko Health AB devices